SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 3 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $16,000 | -90.2% | 16,466 | -88.0% | 0.00% | -100.0% |
| Q1 2022 | $163,000 | -57.9% | 137,156 | +15.6% | 0.00% | -50.0% |
| Q4 2021 | $387,000 | -16.2% | 118,632 | +14.8% | 0.00% | 0.0% |
| Q3 2021 | $462,000 | +11.6% | 103,307 | +35.8% | 0.00% | 0.0% |
| Q2 2021 | $414,000 | +55.1% | 76,052 | +163.7% | 0.00% | 0.0% |
| Q2 2019 | $267,000 | -75.4% | 28,838 | -75.7% | 0.00% | -71.4% |
| Q1 2019 | $1,086,000 | +59.0% | 118,861 | -3.0% | 0.01% | +40.0% |
| Q4 2018 | $683,000 | -51.7% | 122,561 | +3.3% | 0.01% | -37.5% |
| Q3 2018 | $1,413,000 | +34.8% | 118,661 | +15.6% | 0.01% | +33.3% |
| Q2 2018 | $1,048,000 | +40.9% | 102,661 | +79.1% | 0.01% | +20.0% |
| Q1 2018 | $744,000 | +423.9% | 57,311 | +292.2% | 0.01% | +400.0% |
| Q4 2017 | $142,000 | – | 14,611 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |